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Reversible cerebral vasoconstriction syndrome (RCVS) refers to a number of disorders characterized by severe and sudden-onset
(“thunderclap”) headaches and angiographic features of reversible, segmental, multifocal vasoconstriction of cerebral arteries.
Although RCVS generally resolves without significant sequelae, a rare and possibly underrecognized hemorrhagic presentation
has a worse potential course. We report three cases of hemorrhagic RCVS and review the literature. Three females (42, 54, and
33 years old, resp.) presented with severe headache, neurological deficits, and dramatic intracerebral hemorrhage (ICH). Patient 1
presented comatose with a 9 × 4 × 6.6 cm left deep intraparenchymal hemorrhage (IPH) and 1 cm midline shift. She underwent
emergent surgical intervention. Patient 2 had a 3.3 × 1.5 cm left superior frontal IPH that enlarged to 4 × 2.5 cm within 12 hours
with worsening headache and neurological deficits. She was successfully managed nonoperatively. Patient 3, after uncomplicated
pregnancy and delivery, presentedwith a 1.5 cm left superior parietal IPHon postpartumday 7. Two days later, she acutely developed
right hemiplegia. Repeat CT demonstrated a new 3.3 × 1.7 cm left frontal IPH. She was also successfully managed nonoperatively.
Many diverse conditions are grouped within the category of RCVS. Dramatic ICH remains a rare and possibly underrecognized
presenting feature. Prompt diagnosis and management are essential for obtaining the best outcome.
1. Introduction
Reversible cerebral vasoconstriction syndrome (RCVS) refers
to a number of disorders characterized by severe and sudden-
onset (“thunderclap”) headaches and the angiographic fea-
ture of segmental, multifocal vasoconstriction of cerebral
arteries that resolves within 12 weeks of presentation [1, 2].
Presentation can include focal neurological deficits, nausea,
photophobia, and/or seizures; however, there is no exclusive
cardinal feature specific to RCVS. Due to the necessity of a
follow-up diagnostic angiogram, the diagnosis during acute
presentation is principally one of exclusion.
Many factors have been tied to the onset of RCVS,
including the postpartum period, exposure to blood prod-
ucts, exposure to vasoactive drugs, migraines, hypertension,
neoplasms, trauma, and increased intracranial pressure due
to bending over, coitus, or valsalva [1, 2]. The diversity
of possible triggering conditions and presentations means
nearly every clinical setting can encounter RCVS, and those
varied specialty encounters have led to numerous designa-
tions throughout the years, including thunderclap headache
with reversible vasospasm [3], migrainous vasospasm [4],
migrainous angiitis [5], benign angiopathy of the central
nervous system [6, 7], CNS pseudovasculitis [8], isolated
benign cerebral vasculitis [9], Call or Call-Fleming syndrome
[10], postpartum angiopathy [11], and drug-induced cerebral
arteritis [12]. Considerable work has sought to align these
varied designations under the banner of RCVS, thus eluci-
dating the ties between the aforementioned conditions and
providing some insight into its course [13].
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Figure 1: Cranial CT without contrast demonstrating a 9 × 4
× 6.6 cm left deep intraparenchymal hemorrhage without any
associated SAH, with 1 cm midline shift.
RCVS is historically a benign condition; its presentation
thought to mimic more serious conditions like subarachnoid
hemorrhage (SAH). However, awareness of the condition has
grown and angiography is now standard in a variety of clinical
workups. As more angiograms are being performed, RCVS
is identified more frequently and is being associated with
far less benign presentations. In particular, the hemorrhagic
presentation is now increasingly recognized and is associ-
ated with a potentially more sinister course, indicating the
need for prompt diagnosis and treatment [14, 15]. Dramatic
intracerebral hemorrhage (ICH) remains a rare and possibly
underrecognized presenting feature of RCVS. In this light,
we report three such cases and review the current data,
theories of etiology, and treatment strategies for RCVS with
hemorrhagic presentation.
2. Case Reports
2.1. Case 1. A 42-year-old female with history of migraines
experienced recurrent, sudden-onset, severe headaches for
four days prior to her day of admission. On the day of
admission, she developed headache after sexual intercourse
and used her standard sumatriptan dose. Approximately four
hours later, her partner noticed expressive aphasia and right-
sided paresis. She worsened progressively and presented to
the ED in a comatose state. Initial CT showed a 9 × 4 ×
6.6 cm left deep intraparenchymal hemorrhage (IPH), left
lateral ventricle compression, and 1 cm midline shift without
any associated SAH (Figure 1). She underwent emergent
left decompressive craniectomy, with hematoma evacuation
and ventriculostomyplacement. Cerebral angiogramdemon-
strated severe multifocal vasoconstriction but was with-
out any evidence of arteriovenous shunting or aneurysms
Figure 2: Bilateral internal carotid artery angiography, lateral view,
demonstrating severe multifocal vasoconstriction but without any
evidence of arteriovenous shunting or aneurysms.
Figure 3: Left vertebral artery angiography, AP, and lateral views,
demonstrating severe multifocal vasoconstriction but without any
evidence of arteriovenous shunting or aneurysms.
(Figures 2 and 3). A one-week follow-up angiogram doc-
umented improvement of vasoconstriction and the three-
month follow-up angiogram demonstrated complete reso-
lution. Extensive workups for vasculitic, immunologic, and
infectious causes were negative along with essentially normal
CSF analysis and leptomeningeal biopsy results. Cranial MRI
evaluations did not demonstrate any unexpected findings.
She made significant neurological improvement with a Mod-
ified Rankin Scale of 3 at three months.
Review of this patient’s chart for additional potential
contributing factors revealed a long-standing history of
migraines treated with sumatriptan, several weeks’ use of
over-the-counter ephedra for weight loss, and admission BP
>180/90mmHg.
2.2. Case 2. A 54-year-old female presented to the ED with
five-hour history of severe headache, nausea, mild expressive
aphasia, acalculia, and mild perseveration. She experienced
acute onset of the headache and nausea, which occurred
specifically while bending over to pick up her grandchild.
Headache and nausea persisted and the additional neurolog-
ical findings manifested over the next several hours. Initial
CT demonstrated a 3.3 × 1.5 cm left superior frontal IPH
with 2mmmidline shift and minimal adjacent subarachnoid
component (Figure 4(a)). Twelve hours later, she experienced
increasing headache and worsening neurological deficits.
A repeat CT demonstrated interval hematoma expansion,
now measuring approximately 4 × 2.5 cm (Figure 4(b)).
The subsequent cerebral angiogram demonstrated severe
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Figure 4: Initial cranial CT without contrast (a) and CT 12 hours later (b). A primary left superior frontal hematoma (3.3 × 1.5 cm) with
minimal subarachnoid hemorrhage (a); significant hematoma expansion (4 × 2.5 cm) is evident on the repeat CT (b).
multifocal vasoconstriction without any evidence of arteri-
ovenous shunting or aneurysms. Although she was success-
fully managed nonoperatively and was making an excellent
neurological recovery, one week follow-up angiogram doc-
umented worsening of vasoconstriction. The three-month
follow-up angiogram demonstrated complete resolution.
Extensive workups for vasculitic, immunologic, and infec-
tious causes were negative along with essentially normal
CSF analysis and leptomeningeal biopsy results. Cranial MRI
evaluations did not demonstrate any unexpected findings.
She achieved complete neurological recovery with aModified
Rankin Scale of 0 at three months.
Review of this patient’s chart for additional potential
contributing factors revealed a long-standing history of
hypertension treatedwith hydrochlorothiazide, an admission
BP >150/80mmHg, and alcohol use approximated at four
glasses of wine per night without binge episodes.
2.3. Case 3. A 33-year-old female with a history of inter-
mittent migraine headache for years experienced sudden-
onset of severe headaches, projectile vomiting, and visual
disturbance the evening prior to her day of admission. She
delivered her third child vaginally 6 days earlier without
complication, after an uneventful course of pregnancy. Initial
CT demonstrated a 1.5 cm left superior parietal IPH and
bilateral convexity subarachnoid hemorrhage (Figure 5(a)).
Two days later, she developed acute right hemiplegia and
repeat CT demonstrated a new 3.3 × 1.7 cm left frontal
IPH (Figure 5(b)). The cerebral angiogram demonstrated
severe multifocal vasoconstriction without any evidence of
arteriovenous shunting, aneurysms, or venous sinus throm-
bosis. She was successfully managed nonoperatively. The
three-month follow-up angiogram demonstrated complete
resolution. Extensive workups for vasculitic, immunologic,
and infectious causes were negative. Cranial MRI evaluations
did not demonstrate any unexpected findings. She made
excellent neurological recovery with aModified Rankin Scale
of 1 at three months.
Review of this patient’s chart for additional potential con-
tributing factors revealed history of mild to moderate inter-
mittent migraine headache approximately every 1-2 months
for years without prescription medication treatment. Her last
episode of migraine headache was approximately 2 weeks
before this event. Her admission BPwas>150/80mmHg.Her
pregnancy was uncomplicated with no infection, proteinuria,
hypertension, or preeclampsia.
3. Discussion
This paper profiles three females (42, 54, and 33 years
old) who presented with severe headache and neurological
deficits. They were found to have large ICH and all had
radiographic evidence of segmental, multifocal vasoconstric-
tion. Patient 1 had a 9 cm left deep IPH with 1 cm midline
shift and underwent emergent surgical intervention; patient
2 had a 3.3 × 1.5 cm left superior frontal IPH that enlarged
to 4 × 2.5 cm within 12 hours with increasing headache
and worsening neurological deficits, and she was successfully
managed nonoperatively; patient 3 initially had a 1.5 cm left
superior parietal IPH but developed acute right hemiplegia
two days later with a new 3.3 × 1.7 cm left frontal IPH, and
she was successfully managed nonoperatively. All patients’
initial cerebral angiograms demonstrated diffuse, severe,
short-segmental vasoconstriction in anterior and posterior
circulations, indicating that the vasospasm was not likely
hemorrhage-induced. Three-month follow-up angiograms
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Figure 5: Initial cranial CT demonstrated convexity subarachnoid hemorrhage and a 1.5 cm left superior parietal acute intraparenchymal
hemorrhage (a). Three days later, the patient developed acute right hemiplegia. Repeat CT demonstrating a new 3.3 × 1.7 cm left frontal
intraparenchymal hemorrhage (b).
demonstrated complete resolution of vasoconstriction in all
three patients.
Therewere several other factors present. Patient 1 had sev-
eral days of recurrent, sudden-onset migrainous headaches
and a coitus-induced headache with subsequent triptan use
hours before she developed neurological deficits. Patient 2
developed neurological deficits shortly after initial headache
onset and experienced onset while bending over. Patient 3
developed severe headache and visual symptoms on post-
partum day 7 after an uncomplicated course of pregnancy
and delivery. Patients 1 and 2 had hypertension. Patients
1 and 3 had migraine headaches. Patients 2 and 3 had
evidence of adjacent subarachnoid components. Early follow-
up angiograms showed improvement of vasoconstriction in
patient 1 but worsening vasoconstriction in patient 2. Finally,
at three-month followup, the Modified Rankin Scale scores
were 3 (patient 1), 0 (patient 2), and 1 (patient 3); however, all
three had significant improvements from presentation.
No patients had any indications of aneurysm or other
mass. For patients 1 and 2, CSF analyses were normal, exten-
sive workups for vasculitic, immunologic, and infectious
causes were negative, and leptomeningeal biopsy results were
normal; CSF analysis and leptomeningeal biopsy were not
performed for patient 3. For all 3 patients, cranialMRI did not
demonstrate any unexpected findings. These patients shared
two key risk factors for developing RCVS: sex and age.
3.1. RCVS. Reversible cerebral vasoconstriction syndrome
is a constellation of disorders characterized by prolonged,
segmental vasoconstriction of anterior and posterior cir-
culation arteries. Vasoconstriction can be symptomatic, yet
also can persist after resolution of symptoms. RCVS is most
commonly reported in females in their 4th and 5th decades of
life. Additional factors that may contribute to the etiology of
RCVS include: hypertension, pregnancy, or the postpartum
period and activities that increase intracranial pressure such
as bending over [16], coitus [5, 17, 18], and the use of
vasoactive substances like serotonergics [12, 19], triptans [20],
ergot derivatives [21, 22], or sympathomimetics [23].
3.2. Hemorrhagic Manifestations. RCVS generally presents
with a severe “thunderclap” headache [24], and cases gener-
ally resolve without significant sequelae. A patient’s descrip-
tion of thunderclap headache or SAH can be remarkably
similar (worst headache ofmy life), andRCVShas historically
been considered the more benign etiology [25]. However, a
meta-analysis of case studies [26] and a recent prospective
study [14] show there may be a significant number of
hemorrhagic manifestations either on presentation or within
the 1st week of headache onset, lending a sinister bent to
the syndrome’s potential course and suggesting the need for
emergent diagnosis and treatment.Theprospective study also
suggests that cortical subarachnoid hemorrhage is the most
likely hemorrhagic outcome, a finding in line with other
retrospective studies and individual case studies [27–36].
3.3. Intracerebral Hemorrhage. Compared to SAH, isolated
ICH is a fairly rare potential complication of RCVS, but
one that can result in significant long-term impairment or
death [37, 38]. A large retrospective study from two hospitals’
data found isolated ICH with a frequency of 6% in 139
patients [34]; prospective studies from two headache clinics
and one emergency headache center showed isolated ICH
frequencies of 0% [39], 0% [40] and 3% [14] in 52, 25, and
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89 patients, respectively. In the retrospective study, all ICHs
(with/without SAH and/or infarction) affected nearly 15%
of patients with hemorrhagic outcomes. Ducros et al. [14]
sought potential risk factors in their patient population and
identified female gender and history of migraine as the only
independent risk factors for hemorrhagic manifestation.
3.4. Risk Factors in Our Patients. Two of the three patients
(patient 1 and patient 3) identified in this study had a
history of migraine. Patient 1 required emergent surgical
treatment and while improved greatly from presentation,
still exhibited significant residual neurological deficits at
three-month followup. Patient 3, although initially presented
with severe headaches, visual symptoms, and a 1.5 cm left
superior parietal IPH, developed acute right hemiplegia 2
days later with a new 3.3 × 1.7 cm left frontal IPH. At three-
month followup, while improved greatly from presentation,
she still exhibited residual neurological deficits. Patient 1 had
a history significant for ephedra use, which is associated
with RCVS and stroke [41, 42] and triptan use just before
onset of neurological symptoms. The frequency with which
she used her triptan for migraine relief is unknown, but
ICH and vasospasm have been documented after overuse of
antimigraine medications [20]. It is unclear how these drugs
may affect its severity or progression, but their association
with RCVS and hemorrhage warrants further investigation.
3.5. Pathophysiology. The pathophysiology of RCVS is not
well understood. Due to the rarity of the condition, larger
scale studies to investigate cause are relatively scarce and the
knowledge base borrows heavily from the condition’s similar-
ity to and association with other vasoconstrictive disorders.
Based on the known risk factors that affect vasoconstriction,
current thought is that the condition is a result of an aberrant
sympathetic response. This may be an induced alteration in
response due to vasoactive drugs, an underlying inability to
cope with activities that cause surges in intracranial pressure,
and/or a systemic problem in people with hypertension.
SAHs can trigger cerebral vasospasm, but it is thought
that RCVS and hemorrhage induced vasospasm are truly
different processes because RCVS demonstrates vasocon-
striction that is not limited to the affected hemisphere, and
the headache associated with RCVS resolves long before the
resolution of vasoconstriction, whereas vasoconstriction in
vasospasm is more commonly delayed from the onset of the
hemorrhage, generally limited to the hemorrhage affected
region, and the symptoms typically resolve with the resolu-
tion of vasoconstriction.Thus, the components of the vasoac-
tive milieu responsible for post-SAH cerebral vasospasm,
such as endothelin-1, serotonin, nitric oxide, prostaglandins,
and catecholamines are less likely to be the underlying cause
of RCVS [43]. The association with pregnancy (postpartum
angiopathy) has led people to suggest connections between
RCVS and preeclampsia. Indeed, hypertension is a major
component of both diseases, and levels of placental growth
factors, sFlt-1 and TGF-beta1, known to be elevated in
eclampsia, have been demonstrated in patients with RCVS in
the postpartum period.
At the genetic level, recent work has shown a signifi-
cant association between brain-derived neurotrophic factor
(BDNF) polymorphisms and the severity of vasoconstriction
in people with RCVS [44]. Secreted BDNF is used by
signaling pathways throughout the body, and it was shown
that there are functional polymorphisms with differing levels
of expression [45]. BDNF is hypothesized to have a role in
themodulation of both the sympathetic and parasympathetic
nervous systems [44, 46]. Kasselman et al. [47] demonstrated
that in the presence of baseline sympathetic overactivity,
increased levels of BDNF trigger perivascular inflammation
and vasoconstriction. One of the polymorphisms with higher
expression levels was then associated with higher levels of
serum C-reactive protein and unstable angina [48], and it
is this form that was associated with more severe vasocon-
striction in patients with RCVS. Thus, a picture emerged
wherein people with particular polymorphisms would not
only have increased levels of BDNF, but also have subsequent
dysregulation of their autonomic nervous systems that would
increase their susceptibility for vasoconstriction. However,
the tendency of this dysregulated state to produce perivascu-
lar inflammation, which is not seen in RCVS, suggests we do
not have the full picture yet and more work needs to be done.
3.6. Treatment. Treatment modalities for RCVS are being
explored. The signs and symptoms of RCVS can mimic
those of readily assessed acute processes such as ICH or
infarct but can also resemble those of more long-term
processes such as primary angiitis of the central nervous
system (PACNS). Differentiation of these chronic conditions
requires some time, andduring this intervening time, patients
are often treated symptomatically, with a calcium channel
blocker and/or with glucocorticoids. As of yet, no studies
have closely examined the effectiveness of these therapies
alone or combined, but a retrospective analysis shows that
patients with glucocorticoid treatment trend toward poorer
outcomes. Given the importance of time-to-treatment of
steroids with PACNS and trend to harm if RCVS patients
receive glucocorticoids, there should be careful investigation
of the frame of onset before treating with steroids.
In regard to calcium channel blockers, there have been
no prospective, randomized, placebo-controlled studies to
investigate their efficacy. Nimodipine is reportedly the most
widely used treatment, and while case series indicated there
was a more rapid improvement in headache, there were
apparently no other outcomes that were improved with
nimodipine as compared to conservative, symptomatic treat-
ment [34, 49]. Likewise, use of verapamil was associated
with radiographic improvement but was not associated with
improved clinical outcomes [50].
4. Conclusion
Our study identified three patients who presented to the
ED with severe, sudden-onset headaches and neurological
deficits. All had dramatic ICH, and two also demonstrated
a subarachnoid component, with no evidence of ruptured
or unruptured aneurysm or subdural hematoma. All had
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multiple risk factors for RCVS and segmental multifocal con-
striction of cerebral arteries was demonstrated by angiogram.
The short-segment constrictions were seen in both hemi-
spheres and affected both the anterior and posterior circula-
tion, lessening the likelihood that the constrictions observed
were hemorrhage-induced vasospasm. For all three patients,
three-month follow-up angiograms demonstrated complete
resolution of the vasoconstriction. Given the patient presen-
tations and negative workups for immunologic, infectious,
and vasculitic etiologies, it is most likely that these patients
hadRCVSwith hemorrhagicmanifestation, rather than other
vasoconstriction syndromes [51, 52]. The three had varied
clinical presentations, varied hospital courses, and the only
common risk factors were their sex and age. These patients
were all identified after hemorrhage had occurred.
Currently, many diverse conditions are grouped within
the category of RCVS; yet, they may or may not share
the same underlying pathophysiology. Although there is an
increased awareness of hemorrhagic presentations of RCVS,
dramatic ICH remains a rare and possibly underrecognized
presenting feature of RCVS. Familiarity with this clinical
entity for prompt diagnosis and management is essential
for cerebrovascular neurosurgeons, vascular neurologists,
neurocritical care physicians, and neurohospitalists to create
the best possible patient outcome.
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